Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Mirvat Alasnag
Research Area(s) / Expertise:

Expertise

 Job title: Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a… View more
Patrick W Serruys
Job title: Professor of Interventional Medicine
Professor Patrick W. Serruys was born in Belgium in 1947. He completed his medical degree (M.D.) at the University of Leuven in 1972 and initially pursued research in muscle physiology before moving into cardiology, setting the stage for a lifelong career in interventional cardiovascular medicineProf Patrick W. Serruys is widely regarded as one of the most influential interventional cardiologists… View more
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
Added: 2 years ago Source:  European Renal Association
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular disease but without diabetes.1Unveiling the results today at the 61st ERA Congress, researchers presented the impressive secondary analysis from the SELECT (Semaglutide… View more

Cardiovascular Kidney Metabolic
Treatment Options and Continuity of Care in MAFLD
Author(s): Carmen Lara-Romero , Manuel Romero-Gómez Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic